JPRN-UMIN000046329招募中未知
A Study on Improvement of Internal Dose Assessment Methods for Patients due to Inhalation of Radioactive Materials in Nuclear Disaster - A Study on Improvement of Internal Dose Assessment Methods for Patients due to Inhalation of Radioactive Materials in Nuclear Disaster
ational Institutes for Quantum Science and Technology0 个研究点目标入组 30 人开始时间: 2021年12月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Persons who have been or may be found to have coerced a socially vulnerable person Persons who have undergone a nuclear medicine examination within one month (within one week in the case of PET examination), or who have received or are receiving radiation therapy (internal radiation therapy). Persons who are judged by the researcher of the research institution to be inappropriate for this research.
研究者
相似试验
已完成
不适用
A study aiming to improve the dosimetric accuracy of spot-scanning proton therapyMalignancyJPRN-UMIN000022765Hokkaido University Hospital150
进行中（未招募）
1 期
A study to assess the efficacy and tolerance of AF-219 in patients with long term coughEUCTR2015-000474-35-GBAfferent Pharmaceuticals, Inc.59
进行中（未招募）
1 期
A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis PatientsModerate to Severe left-sided Active Ulcerative ColitisEUCTR2016-004217-26-HUInDex Pharmaceuticals AB215
进行中（未招募）
1 期
A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis PatientsModerate to Severe left-sided Active Ulcerative ColitisEUCTR2016-004217-26-SEInDex Pharmaceuticals AB215
进行中（未招募）
1 期
A Randomised Dose-Optimisation Study to Evaluate the Efficacy and Safety of Cobitolimod in Moderate to Severe Active Ulcerative Colitis PatientsEUCTR2016-004217-26-ITINDEX PHARMACEUTICALS AB215